ANXIOLYTICS IN MRDD

Saved in:

WERRY, J.S., ANXIOLYTICS IN MRDD. MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, Vol. 5, no. 4 (1999), p. 299-304.

Ref. 83243

Location: SIIS R.1376

Solicitar documento

Palabras clave:
Ansiedad, Discapacidad intelectual, Efectos, Fármacos, Trastornos de la conducta, Tratamiento

Similar Items: ANXIOLYTICS IN MRDD

Quick Look
Quality of life, pain and use of analgesic, anxiolytic and antidepressant medication, in people living in care homes
Quick Look
ANXIOLYTICS, ADRENERGIC AGENTS, AND NALTREXONE
Quick Look
BETA-ADRENERGIC BLOCKERS IN MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES
Quick Look
EFFECTS OF RISPERIDONE ON DESTRUCTIVE BEHAVIOR OF PERSONS WITH DEVELOPMENTAL DISABILITIES: III. FUNCTIONAL ANALYSIS
Quick Look
SEPARATE AND COMBINED EFFECTS OF METHYLPHENIDATE AND A BEHAVIORAL INTERVENTION ON DISRUPTIVE BEHAVIOR IN CHILDREN WITH MENTAL RETARDATION
Quick Look
TRATAMIENTO COMUNITARIO DE LOS TRASTORNOS DE ANSIEDAD: ¿COGNITIVO-CONDUCTUAL, FARMACOLOGICO O MIXTO?
Quick Look
USING ANALOG BASELINES TO ASSESS THE EFFECTS OF NALTREXONE ON SELF-INJURIOUS BEHAVIOR
Quick Look
THE PREPARATION AND TRAINING OF THE EDUCATIONAL COMMUNITY FOR THE INCLUSION OF STUDENTS WITH DEVELOPMENTAL DISABILITIES: THE MRDD POSITION
Quick Look
Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability
Quick Look
THE USE OF ANTI-PSYCHOTIC DRUGS WITH ADULTS WITH LEARNING DISABILITIES AND CHALLENGING BEHAVIOUR
Quick Look
RISPERIDONE FOR SEVERELY DISTURBED BEHAVIOR AND TARDIVE DYSKINESIA IN DEVELOPMENTALLY DISABLED ADULTS
Quick Look
USING THE DIAGNOSTIC ASSESSMENT OF THE SEVERELY HANDICAPPED-II (DASH-II) TO MEASURE THE THERAPEUTIC EFFECTS OF RISPERIDONE
Quick Look
REVIEW OF SEROTONERGIC AGENTS AND PERSERVATIVE BEHAVIOR IN PATIENTS WITH DEVELOPMENTAL DISABILITIES
Quick Look
PAROXETINE TREATMENT OF AGGRESSION AND SELF-INJURY IN PERSONS WITH MENTAL RETARDATION
Quick Look
B-ENDORPHIN AND ACTH ARE DISSOCIATED AFTER SELF-INJURY IN ADULTS WITH DEVELOPMENTAL DISABILITIES
Quick Look
Quality of diagnosis and treatment plans after using the ‘diagnostic guideline for anxiety and challenging behaviours’ in people with intellectual disabilities: a comparative multiple case study design
Quick Look
ANTIPSYCHOTIC MEDICATION FOR CHALLENGING BEHAVIOR IN PEOPLE WITH INTELLECTUAL DISABILITY: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
Quick Look
Psychotropic drug prescription in nursing homes during the Covid-19 pandemic
Quick Look
EFFECTS OF RISPERIDONE ON ABERRANT BEHAVIOR IN PERSONS WITH DEVELOPMENTAL DISABILITIES: II. SOCIAL VALIDITY MEASURES
Quick Look
ASPECTOS MEDICOS EN EL ANALISIS FUNCIONAL DEL COMPORTAMIENTO PROBLEMATICO. EN : HACIA UNA CONCEPCION DE LA DISCAPACIDAD
Quick Look
RESPONSE TO METHYLPHENIDATE IN CHILDREN WITH ADHD AND COMORBID ANXIETY
Quick Look
THE EFFECT OF BUSPIRONE ON CHALLENGING BEHAVIOUR IN MENTALLY REARDED PATIENTS: AN OPEN PROSPECTIVE MULTIPLE-CASE STUDY
Quick Look
FLUOXETINA Y TRASTORNO DE ANGUSTIA
Quick Look
PSYCHOPHARMACOLOGICAL INTERVENTIONS IN FRAGILE X SYNDROME, FETAL ALCOHOL SINDROME, PRADER-WILLI SYNDROME, ANGELMAN SYNDROME, SMITH-MAGENIS SYNDROME, AND VELOCARDIOFACIAL SYNDROME